Measuring Symptom Distress in Cancer Patients
common.study.values.description
“New Assessment System in Measuring Symptom Distress in Cancer Patients”
This trial studies how well a new assessment system (MDASI or other MD Anderson-developed PRO instrument) works in measuring symptoms and the impact on quality of life in cancer patients. Development of a new assessment system may provide more information about the common symptoms that may occur in patients due to cancer and its treatment and how the symptoms impact quality of life.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-no
Interview
Complete interview
Quality-of-Life Assessment
Complete quality of life assessment
Questionnaire Administration
Complete questionnaires
participant.views.study.view.additional
participant.views.study.view.scientific-title
Measuring the Symptom Distress of Cancer Patients: Development of a New Assessment System
common.study.values.clinical-trial-id
NCT00505245
participant.views.study.view.id
ZdPNwa
